The process flow for risk management based on ISO 14971 is as below According to clause 3 in ISO 14971, top management must:
As with other management standards, people who perform risk assessment should be competent and knowledgeable (e.g., through trainings & experience on ISO 14971, medical device application, etc.).
Risk management process flow as per ISO 14971
Another important element in risk management (to ensure traceability) is a risk management file, which is established for every medical device. The file is used to keep record of:
The risk management file will be used to gather all information related to risk, even in post-production situations.
The process of risk management has the following steps:
1) Risk analysis – Risk analysis is performed on each medical device, and possible hazards are identified. Risk is estimated for each hazardous situation. Characteristics that can foreseeably affect the safety of the medical device are also listed. Risk analysis should also incorporate a combination of hazardous events that can result in a hazardous situation, whereas reasonably foreseeable combinations of such events should be analyzed separately. For example, when a heel stick is used to collect blood from infants for testing, the blood is warmed with a chemical pack. The sudden rupturing of this chemical pack is a foreseeable effect of the characteristics of the chemical pack, and the hazardous event is a combination of the heel stick used for collecting the sample (likely a negligible hazard) and the chemical pad used to ease the process of sampling. The risk management file is updated accordingly based on all analysis results.
2) Risk evaluation – Each hazardous situation is studied, and then the organization’s risk acceptability criteria are used to confirm whether risk reduction is needed for this hazard or not. The results of risk evaluation activities are also recorded in the file. Risk evaluation is normally done by multiplying the severity of the hazard by the likelihood of its occurrence.
3) Risk control – Risk control is a risk reduction process in which an unacceptable risk is minimized. The effectiveness of the control is measured by reevaluation of residual risk, i.e., remaining risk after the control is implemented. Sometimes, controls allocated to minimize a risk add another risk hazard – such controls are ineffective until, and unless, the new risks are within acceptable range or controlled within acceptable limits. A risk control is chosen from the available options based on the following factors:
When implemented, risk controls are verified. If the residual risk is unacceptable, a risk benefit analysis is conducted. If an additional control is impractical, then the risk benefit analysis should dictate whether the medical benefits of the device outweigh the residual risk. Records of each step of risk control are maintained in the risk management file, which includes control options, selection of control, risk control review, control verification, residual risk calculation, risk benefit analysis, etc.
4) Residual risk evaluation – Residual risk evaluation is done after all controls are in place and effective. A file is maintained with the risk management register after all risks have been properly controlled, and records are maintained. Any change may require reevaluation of overall residual risks.
5) Risk management report – Just as management reviews are planned for the Quality Management System, likewise, such reviews should be planned for the risk management system. Before a medical device enters the commercial market, a review should be conducted. Based on the review, a risk management report is prepared. The report should include the results of the review and be incorporated into the risk management file as mentioned ISO 14971.
6) Information from production and post-production – A system for monitoring the performance of the medical device should be developed, established, and maintained as mentioned in ISO 14971. The results should be recorded in the risk management file. Information that comes from production includes any defects or failures in clinical trials, and results of post-production include any customer complaints or product failures that may increase the risk (because of increased likelihood of occurrence).
With the help of a risk management system based on ISO 13485 and ISO 14971, each phase of a risk management cycle is documented comprehensively to demonstrate the manufacturer’s commitment to controlling risk in the life of the medical device. A strong risk management system as per ISO 14971 also provides significant value by helping with the development, manufacture, and delivery of new medical devices. Devices under development are subject to higher levels of scrutiny. Also, ISO 14971 risk management system helps with documenting modifications to ensure product safety, functionality, and usability.
At Maven, we have a team of Experts in product knowledge as well as Standard compliance. We can tailor your Risk management report as per ISO 14971 according to your product requirements.
Call us for assistance.
Amended transition timelines of Regulations (EU) 2017/745 and (EU) 2017/746Read More
European Commission to consider extensions to MDR and IVDR deadlines?Read More
Quantification of Benefit – Risk AnalysisRead More